REGULATORY

• Chuikyo OKs Drug Price Survey Plan for FY2024 Revision
  June 22, 2023

• Japan Diet Ends Ordinary Session, All 7 MHLW-Submitted Bills Enacted
  June 22, 2023

• MHLW Panel Discusses 6 Risks to Drug Supplies; Need for Industry Consolidation Raised
  June 21, 2023

• MHLW to Set Up Separate Forums Focused on Generics and Drug Lags to Execute Expert Panel Proposals
  June 21, 2023

• Ryukaikon to Meet June 26 to Discuss Expert Panel Proposals
  June 21, 2023

• MHLW Study Group to Develop Company Indicators for Generic Supply Systems in FY2023
  June 20, 2023

• Relief Claims OK’ed for 5 More Deaths Possibly Linked to COVID Jabs
  June 20, 2023

• MHLW Study Group Proposes Flexibility in Launch Premium Criteria, Broader Comparators
  June 20, 2023

• MHLW Starts Clinical Study on Mpox Vaccine for People with High Infection Risks
  June 19, 2023

• PMDA to Establish Asia, US Hubs to Spur Innovative Drug Development
  June 19, 2023

• Japan OKs Honebuto Budget Policy Blueprint, Vows Debates on Longer-Term Drug Costs
  June 19, 2023

• Democratic Party For the People Calls for Drug Pricing Overhaul
  June 16, 2023

• First Generics for 11 APIs to Enter NHI Price List, Azilva Faces Most Contenders
  June 15, 2023

• MSD’s Lyfnua Braces for Price Cuts under CEA Scheme
  June 15, 2023

• Japan Diet Clears Lawmaker-Sponsored Dementia Bill
  June 15, 2023

• MHLW Mulls New OTC Class to Bar Online Sales amid Unease over Morning After Pills
  June 14, 2023

• LDP Policy Research Council Generally Approves Revised Honebuto Draft
  June 14, 2023

• Label Revision Ordered for Opdivo, Yervoy to Add Meningitis Risks
  June 14, 2023

• MHLW to Set Up Team Dedicated to Executing Healthcare DX Timeline
  June 13, 2023

• 3 Japan Manufacturers of Plasma-Derived Products Call for Changes in Export Rules: PAFSC Committee
  June 13, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• 94
• …
• Next ›
• 最終 »